GlassScriptPhysician profile
Mudassir Syed
NPI 1518429018
$993.52
in general payments reported to CMS, 2019-2025
9 companies · $329 in 2025
The $329 reported for 2025 was more than what a typical Diagnostic Radiology provider received nationally (typical 2025 total: $112).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $16.89 · 2024: $647 · 2025: $329.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $994.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $993.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $410.86 | 2024-2025 | Therasphere Y90 Glass Microspheres 10 Gbq |
| Cook Medical LLC | $143.31 | 2024 | Zenith Spiral-Z |
| Ge Healthcare | $124.43 | 2024 | |
| Penumbra, INC. | $119.00 | 2024 | Ruby Coil |
| Medtronic, INC. | $100.90 | 2024 | Endurant Iis |
| Bard Peripheral Vascular, INC. | $45.89 | 2025 | Denali Vena Cava Filter |
| Terumo Medical Corporation | $17.97 | 2024 | Navicross, Azur Cx Detachable |
| Stryker Corporation | $16.89 | 2023 | Spinejack |
| W. L. Gore & Associates, INC. | $14.27 | 2025 | Gore Excluder Thoracoabdominal Branch Endoprosthesis |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mudassir Syed listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.